TAKEDA PHARMACEUTICAL CO LTD
Q2 2025 13F Holdings
- Locationtokyo, M0
- Num holdings
11
- Value ($000)
$19,554
- Date Filed08/07/2025
- Form type13F-HR
- CIK0001395064
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
HLVX HilleVax, Inc. | COM | 43157M102 | $13.38M | 68 % | 6,724,000 | ||
OVID Ovid Therapeutics, Inc. | COM | 690469101 | $2.49M | 13 % | 7,531,996 | ||
XLO Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics) | COM | 98422T100 | $1.00M | 5 % | 1,475,121 | ||
AMWL American Well Corporation | COM | 03044L204 | $691.05K | 4 % | 77,733 | ||
EQ Equillium, Inc. | COM | 29446K106 | $575.23K | 3 % | 1,824,977 | ||
STTK Shattuck Labs, Inc. | COM | 82024L103 | $408.27K | 2 % | 515,619 | ||
LYEL Lyell Immunopharma, Inc. | COM | 55083R104 | $363.91K | 2 % | 41,165 | ||
TSBX Turnstone Biologics | COM | 90042W100 | $321.60K | 2 % | 895,824 | ||
Third Harmonic Bio, Inc. | COM | 88427A107 | $200.01K | 1 % | 36,835 | ||
RANI Rani Therapeutics Holdings, Inc. | COM | 753018100 | $104.42K | 1 % | 203,190 |
Rows Per Page
10
- 10
- 50
- 100